Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019).

doi:10.1089/AID.2023.0083

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019).

AIDS research and human retroviruses - 1 Aug 2024

Laufer Natalia L, Bouzas María B, Fernández Giuliano Silvina, Zapiola Ines, Mammana Lilia, Salomon Horacio, Monzani Cecilia, Castro Gonzalo, Suarez Ornani Maria Laura, Rojas Machado Paula, Cochon Natalia, Adazsko Ariel, Ravasi Giovanni, Vila Marcelo, Maulen Sergio, Ceriotto Mariana, Barbas María Gabriela, Martini Sergio

Abstract excerpt

More than 62,000 individuals are currently on antiretroviral treatment within the public health system in Argentina. In 2019, more than 50% of people on ART received non-nucleoside reverse transcriptase inhibitors (NNRTIs). In this context, the second nationwide HIV-1 pretreatment drug resistance surveillance study was carried out between April and December 2019 to assess the prevalence of HIV-1 drug resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Argentina

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to HIV-1

Share to HIV Infections

Share to Reverse Transcriptase Inhibitors

Share to World Health Organization

Source

Open in PubMed

Identifiers

PMID: 38386507
DOI: 10.1089/AID.2023.0083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019).PMID 38386507Read ↗

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients.Semantic proximity Read ↗

National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing.Semantic proximity Read ↗

Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.Semantic proximity Read ↗

Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.Semantic proximity Read ↗

[HIV-1 resistance to antiretroviral drugs in pregnant women from Buenos Aires metropolitan area].Semantic proximity Read ↗

Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.Semantic proximity Read ↗

Drug resistance in children and adolescents with HIV in Panama.Semantic proximity Read ↗

Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021-2023.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.Semantic proximity Read ↗

Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.Semantic proximity Read ↗

[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.